Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Pending presbyopia treatments edge closer to disrupting the marketspace
-
- Artificial intelligence, machine learning making strides in ophthalmology
- Cryopreserved amniotic membrane can treat compromised ocular surface Alice T. Epitropoulos, MD, FACS
- Game-changing technology, objective testing en route to revolutionizing dry eye management
- ProQR Therapeutics sets goals for 2023
- Quarterly dosing may become reality for wet AMD
- Roche to acquire Spark Therapeutics
- When IOL calculations give different results, which do you choose? Uday Devgan, MD
- Monovision via LASIK or inlay: A presbyopia debate Sumitra S. Khandelwal, MD; Priyanka Sood, MD
-
- Boy presents with severe unilateral loss of vision over 3-month period David Reese, MD; James Constans, MD
- Medication use lower 2 years after combined iStent implantation, cataract surgery
- More options coming for patients with presbyopia Richard L. Lindstrom, MD
- Lindstrom: Opportunity remains despite worrisome megatrends in health care
- Negative dysphotopsia improves with occlusion of contralateral eye
- NEI funding supports trial of virtual reality glaucoma detection device
- Non-technical skills help reduce surgical errors
- VIDEO: Dropless formula useful for cataract surgery in mission setting
-
- VIDEO: Eyenovia’s MicroStat shows positive phase 3 data Michael Rowe
- VIDEO: Pearls for optimizing refractive enhancements
- Will a miotic agent or an agent that restores lens elasticity be more of an impactful pharmacologic therapy to treat presbyopia?
- On the horizon and over the rainbow Darrell E. White, MD